SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021121
Filing Date
2020-11-12
Accepted
2020-11-12 16:45:34
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 604081
2 ex10-1.htm EX-10.1 70954
3 ex31-1.htm EX-31.1 10644
4 ex31-2.htm EX-31.2 10606
5 ex32-1.htm EX-32.1 4374
6 ex32-2.htm EX-32.2 4290
  Complete submission text file 0001493152-20-021121.txt   4329129

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE aim-20200930.xml EX-101.INS 731003
8 XBRL SCHEMA FILE aim-20200930.xsd EX-101.SCH 74004
9 XBRL CALCULATION FILE aim-20200930_cal.xml EX-101.CAL 61628
10 XBRL DEFINITION FILE aim-20200930_def.xml EX-101.DEF 218044
11 XBRL LABEL FILE aim-20200930_lab.xml EX-101.LAB 451190
12 XBRL PRESENTATION FILE aim-20200930_pre.xml EX-101.PRE 294584
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 201307506
SIC: 2836 Biological Products, (No Diagnostic Substances)